Clinical trial
Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction
NCT00390312 · Javelin Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00390312 |
|---|---|
| Title | Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction |
| Official title | Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Single Dose Comparison of Analgesic Efficacy and Safety of Intranasal Morphine, Immediate Release Oral Morphine, Intravenous Morphine and Placebo in Postsurgical Dental Pain |
| Lead sponsor | Javelin Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Post-Operative Pain, Third Molar Extraction |
| Intervention type | Drug |
| Interventions | Intranasal Placebo, Intranasal Morphine 15 mg, Immediate Release Oral Morphine 60 mg, Intravenous morphine, Intranasal morphine 7.5 mg, Oral placebo, Intravenous placebo |
| Enrollment | 225 |
| Start date | Sep 1, 2001 |
| Primary completion | Nov 1, 2001 |
| Completion | Nov 1, 2001 |
| First posted | Oct 19, 2006 |
| Last update posted | Jan 4, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: